MetLife Investment Management’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,951
| Closed | -$70.2K | – | 2792 |
|
|
2024
Q4 | $70.2K | Hold |
5,951
| – | – | ﹤0.01% | 2709 |
|
|
2024
Q3 | $123K | Buy |
+5,951
| New | +$123K | ﹤0.01% | 2544 |
|
|
2020
Q3 | – | Sell |
-1,038
| Closed | -$261K | – | 2306 |
|
|
2020
Q2 | $261K | Hold |
1,038
| – | – | ﹤0.01% | 1741 |
|
|
2020
Q1 | $163K | Buy |
1,038
+262
| +34% | +$41.2K | ﹤0.01% | 1805 |
|
|
2019
Q4 | $127K | Hold |
776
| – | – | ﹤0.01% | 2204 |
|
|
2019
Q3 | $113K | Sell |
776
-459
| -37% | -$67K | ﹤0.01% | 2269 |
|
|
2019
Q2 | $257K | Buy |
1,235
+465
| +60% | +$96.6K | ﹤0.01% | 1886 |
|
|
2019
Q1 | $160K | Hold |
770
| – | – | ﹤0.01% | 2094 |
|
|
2018
Q4 | $135K | Hold |
770
| – | – | ﹤0.01% | 2140 |
|
|
2018
Q3 | $174K | Hold |
770
| – | – | ﹤0.01% | 2163 |
|
|
2018
Q2 | $117K | Hold |
770
| – | – | ﹤0.01% | 2149 |
|
|
2018
Q1 | $141K | Hold |
770
| – | – | ﹤0.01% | 2074 |
|
|
2017
Q4 | $164K | Buy |
+770
| New | +$164K | ﹤0.01% | 2024 |
|